GB
GDRX icon

Gavin Baker’s GoodRx Holdings GDRX Stock Holding History

Gavin Baker’s Portfolio GDRX Stock Details GDRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-2,313,994
Closed -$94.9M – 40
2021
Q3 		$94.9M Sell
2,313,994
-1,117,901
-33% -$40.6M 2.24% 17
2021
Q2 		$124M Buy
+3,431,895
New +$127M 2.21% 13

Other funds holding GDRX

FPM
Francisco Partners Management San Francisco, California $361M AUM 30.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
ACA
Abdiel Capital Advisors New York $51.8M AUM 18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
SLG
Silver Lake Group Menlo Park, California $4.58B AUM 24.86% 1-Year Est. Return
Tiger Global Management
Tiger Global Management New York $24B AUM 39.59% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $7.71B AUM 4.02% 1-Year Est. Return
TCMX
Technology Crossover Management X Menlo Park, California $795M AUM 5.23% 1-Year Est. Return

Gavin Baker's GDRX Position: Q4 2021 in Review

Gavin Baker sold out of GoodRx Holdings (GDRX) in Q4 2021, closing a stake of 2,313,994 shares — an estimated $94.9M sold.

Gavin Baker first reported a position in GDRX in Q2 2021 and held it in 2 quarters. The position peaked at $124M in Q2 2021. 216 funds tracked by Wall St. Rank hold GDRX as of Q4 2021.

  • Gavin Baker reported no remaining GoodRx Holdings position as of Q4 2021 after selling out during the quarter.
  • Gavin Baker sold 2,313,994 GoodRx Holdings shares in Q4 2021, an estimated $94.9M.
  • Gavin Baker first reported a position in GoodRx Holdings in Q2 2021 and held it in 2 quarters.
  • Gavin Baker's GoodRx Holdings position peaked at $124M in Q2 2021.
  • 216 funds tracked by Wall St. Rank held GoodRx Holdings as of Q4 2021.

Based on Atreides Management's 13F filing for Q4 2021, filed 14 Feb 2022.